#None #Paris #Stroke Treatment #Terumo Neuro #SOFIA Flow 88

Expanding Stroke Care Innovations with SOFIA™ Flow 88

In a significant development for neurovascular treatment, Terumo Neuro has announced the commercial launch of its SOFIA™ Flow 88 Neurovascular Aspiration Catheter across the EMEA region. This launch comes as part of Terumo's ongoing commitment to improving stroke care through innovation and clinical excellence.

The SOFIA™ Flow 88 is engineered for exceptional reliability and procedural flexibility, making it a valuable addition to Terumo's extensive stroke portfolio. Notably, the catheter boasts a large-bore design and has been developed through a decade of clinical performance feedback and physician collaboration. With over 500,000 procedures conducted worldwide, the SOFIA™ catheter line continues tobe a trusted choice among healthcare professionals.

Features and Benefits of the SOFIA™ Flow 88

a) Reliable Reach and Navigation: The catheter features an optimized design that ensures reliable trackability, allowing improved navigation through challenging anatomical structures. Its soft, atraumatic distal tip is designed to minimize trauma during the procedure.

b) Enhanced Procedural Stability: The proximal stability provided by the catheter is aimed at simplifying both short and long procedures, ensuring that healthcare providers have the support needed exactly when they need it.

c) Atraumatic Design: The flexibility and reinforcement of the catheter throughout its length greatly reduce the risk of vessel trauma while supporting effective navigation.

d) Optimized Clot Engagement: Using advanced technology, the proprietary tip of the SOFIA™ Flow 88 expands to conform to the clot, enhancing aspiration capabilities during critical procedures.

Clinical Evidence and Applications

The clinical data supporting the SOFIA™ Flow 88 includes insights from the SOFAST registry and SESAME trial, which demonstrated the catheter's effectiveness as a first-line approach in aspiration thrombectomy. Physicians involved in these studies have noted improved outcomes in terms of speed, efficacy, and safety associated with this innovative catheter.

The SOFIA™ Flow 88 is also designed to seamlessly integrate with existing stroke treatment strategies and is compatible with the SOFIA™ Plus 6F Aspiration Catheter. This compatibility allows for a more comprehensive and cohesive approach in managing acute ischemic strokes, further enhancing the effectiveness of neurovascular interventions.

As part of its overall stroke solution portfolio, Terumo Neuro offers a variety of products catering to different needs, including:

• - SOFIA™ and SOFIA™ Plus Aspiration Catheters: Known for their excellent trackability and clinical performance.
• - ERIC™ Retrieval Device: Aimed at providing efficient thrombus control.
• - BOBBY™ Balloon Guide Catheter: Enhancing flow management and procedural preparation.
• - WEDGE™ Microcatheter: Optimized for navigational efficacy.

Commitment to Innovation

Carsten Schroeder, President and CEO of Terumo Neuro, emphasized the company's commitment to neurovascular innovation, stating: "The introduction of the SOFIA™ Flow 88 reflects our ongoing investment in research and development, driven by our collaboration with healthcare providers. Together, we are focused on improving outcomes for patients worldwide facing stroke emergencies."

Looking Ahead

The launch of the SOFIA™ Flow 88 at the LINNC event in Paris marks an exciting milestone in Terumo's journey to advance stroke care. By continually enhancing its product offerings and leveraging robust clinical evidence, Terumo Neuro is poised to contribute significantly to patient care and clinical efficiency in the realm of neurovascular treatments. For more information on the new SOFIA™ Flow 88 Neurovascular Aspiration Catheter and Terumo's broader stroke solutions, visit Terumo Neuro's website.